FIELD: medicine.
SUBSTANCE: for treating Hashimoto disease, simvastatin Vazilip 20 mg once a day in the evening and cytoprotector Mexicor 0.1 1 capsule 3 times a day on an empty stomach for 3 months are introduced.
EFFECT: method provides effective treatment ensured by immune corrective action indicated by anti-thyroid peroxidase autoantibodies level decrease that maintains a functional potential of a thyroid gland.
4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF HYPERTROPHIC AUTOIMMUNE THYREOIDITIS AND DIFFUSE TOXIC GOITER | 2004 |
|
RU2251975C1 |
DIFFERENTIAL DIAGNOSIS METHOD FOR RECOGNIZING TOXIC ADENOMA AND DIFFUSE TOXIC GOITER | 2004 |
|
RU2253369C1 |
METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN HYPOTHYROIDISM | 2019 |
|
RU2732290C1 |
METHOD OF TAKING PREVENTIVE MEASURES AIMED AT TREATMENT OF THYROID GLAND DISEASES IN CHILDREN OF EARLY AGE BORN FROM MOTHERS WITH OPPORTUNISTIC INFECTIONS | 2007 |
|
RU2355447C1 |
METHOD OF TREATING THYROID DYSFUNCTION | 2008 |
|
RU2410077C2 |
DIFFERENTIAL DIAGNOSIS METHOD FOR DISTINGUISHING THE CASES OF THYROID GLAND DISEASES | 2005 |
|
RU2299687C1 |
METHOD OF AFTERTREATMENT OF CHILDREN AND TEENAGERS WITH AUTOIMMUNE THYROIDITIS IN COMBINATION WITH CHRONIC PHARYNGOTONSILLITIS | 2006 |
|
RU2332978C2 |
METHOD OF TREATMENT OF SUBACUTE DE QUERVAIN'S DISEASE USING COLD IR-LASER THERAPY AND NONSTEROID AND STEROID PREPARATIONS | 2007 |
|
RU2345804C1 |
METHOD OF PREDICTING RISK OF METABOLIC SYNDROME DEVELOPMENT IN WOMEN OF PERIMENOPAUSE AGE | 2009 |
|
RU2396912C1 |
METHOD FOR ESTIMATING AUTOIMMUNE THYROIDITIS TREATMENT EFFECTIVENESS | 2006 |
|
RU2323443C1 |
Authors
Dates
2011-01-27—Published
2009-10-12—Filed